SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) February 2, 1999
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission file Number) (IRS
of incorporation) Identification No.)
51 James Way, Eatontown, New Jersey 07724
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (732) 542-2800
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
Osteotech, Inc. announced that it has completed its previously announced
acquisition of a 90% interest in OST Developpement SA ("OST") of
Clermont-Ferrand, France. On June 25, 1998, Osteotech acquired a 5% interest in
OST. On January 25, 1999, the remaining 85% interest in OST was acquired with an
effective date of January 1, 1999. The aggregate cost of the transaction is FFR
9,000,000 (about $1.5 million at current exchange rates). The acquisition is
expected to contribute approximately $4 million in revenues and be accretive to
net income in 1999. The agreement also provides for the future purchase by
Osteotech of the remaining 10% of OST at a price to be determined at the time of
the acquisition of the remaining shares.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: February 8, 1999
OSTEOTECH, INC.
(Registrant)
By: /s/ Michael J. Jeffries
-----------------------------------
MICHAEL J. JEFFRIES
Executive Vice President,
Chief Operating Officer and
Chief Financial Officer
(Principal Financial Officer
and Principal Accounting Officer)
